Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR)

CUSIP: 57055L206

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
-15,000
SEC-reported price per share
$1.47
Number of holders
4
Value change
-$19,500
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,869,505

Security key

57055L206

Report period

Q2 2026

Institutions

4

Top holders

4

Ownership snapshot

Top reported holders of MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Blue Owl Capital Holdings LP
Disclosed value leader
New Enterprise Associates...
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: Blue Owl Capital Holdings LP Showing 1-6 of 15 holder rows.

Quick read

Blue Owl Capital Holdings LP leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Blue Owl Capital Holdings LP's linked filing trail.
Comparable ownership Top 5
Blue Owl Capital Holdings LP 10%
New Enterprise Associates 16, L.P. 9.9%
Alyeska Investment Group, L.P. 9.9%
John R. Wilson 5%
NEA Management Company, LLC 9.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Blue Owl Capital Holdings LP
13D/G 13F
Company
10%
$1,431,356
1,127,052 shares
+$727,459 31 Mar 2025
New Enterprise Associates 16, L.P.
3/4/5 13D/G
10%+ Owner
9.9%
from 13D/G
$5,202,170
1,625,678 shares
23 Dec 2024
Alyeska Investment Group, L.P.
13D/G
9.9%
$1,143,378
1,280,952 shares
+$188,600 30 Sep 2025
John R. Wilson
13D/G 3/4/5
John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017 · Director
5%
641,801 shares
$0 19 Aug 2025
NEA Management Company, LLC
13F
Company
13F
9.6%
$2,113,381
1,625,678 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
2.3%
$506,115
389,319 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
4
Shares
2,504
Rows available
4
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
35
Q2 2026 holders
4
Holder diff
-31
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .